Loading...
Currently trading at $ 0.002534 , which has not changed over the last 24 hours . Market capitalization is $107.3K . Circulating supply: 42,365,415 TRL.
| Date | Price | % Change |
|---|---|---|
| Now | $ 0.002534 | - |
| 1 Hour | $ 0.002534 | 0% |
| 1 day | $ 0.002534 | 0% |
| 7 days | $ 0.002534 | 0% |
| 30 days | $ 0.002498 | -1.43% |
| 60 days | $ 0.002066 | -18.47% |
| 90 days | $ 0.002233 | -11.85% |
| Rank | #2334 |
| Price | $0.00 |
| Market Cap | $107.3K |
| Trading Volume (24h) | - |
Triall (TRL) is ranked #2334 based on its market cap of $107,343.00. TRL is trading at $0.00 where the total trading volume in the last 24h was $0.00.
Triall is a decentralized platform that aims to streamline the clinical trial process using blockchain technology. The platform provides tools and services to help researchers, study participants, and regulators collaborate efficiently and securely. The Triall token (TRL) is the platform's native currency and is used to incentivize users and reward contributors.
The Triall platform enables researchers to easily set up and manage clinical trials while providing a secure and transparent environment for study participants. With Triall, participants can be confident that their data is being handled securely, and they have control over their data. The platform allows researchers to track the progress of the study, ensuring that it meets its goals and deadlines.
The Triall token is an ERC-20 token built on the Ethereum blockchain. The token has a fixed supply of 400 million tokens, with 50% allocated to the public sale, 20% allocated to the team and advisors, 15% allocated to the reserve, and 15% allocated to the ecosystem fund. The token can be used to pay for services on the Triall platform, and users can earn tokens by participating in clinical trials or by contributing to the platform's development.
The Triall team is made up of experts in the healthcare and blockchain industries, bringing together a unique blend of skills and experience. The team is dedicated to creating a platform that can revolutionize the clinical trial process and improve healthcare outcomes for everyone.
Triall has a number of partnerships with healthcare institutions, research organizations, and blockchain companies, which helps to ensure the platform's success. The company has also received funding from a number of sources, including the European Union, which provides additional validation of the platform's potential.
Overall, Triall is a promising project that has the potential to make a significant impact on the clinical trial process. With its focus on security, transparency, and collaboration, the platform could help to accelerate the development of new treatments and therapies, ultimately improving healthcare outcomes for patients around the world.
by Coinando
A smarter way to master crypto
Build a deeper understanding of crypto — from fundamentals to advanced topics.
Join Early AccessExclusive for Coinando users
Sign up for our weekly newsletter to get the latest on all deals. Don't miss out!
